Cargando…
Prevalence of late and long-term effects of cancer (treatment) and use of complementary and alternative medicine in Norway
BACKGROUND: The increasing number of patients surviving cancer leads to more people experiencing late and long term-effects from the disease and its treatment. Fatigue, sleep disorders, early menopause, pain, and nerve damage are commonly reported. Methods helping people to recover after cancer trea...
Autores principales: | Kristoffersen, Agnete E., Wider, Barbara, Nilsen, Jorunn V., Bjelland, Mona, Mora, Dana C., Nordberg, Johanna Hök, Broderstad, Ann Ragnhild, Nakandi, Kiwumulo, Stub, Trine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9721050/ https://www.ncbi.nlm.nih.gov/pubmed/36471296 http://dx.doi.org/10.1186/s12906-022-03790-z |
Ejemplares similares
-
Use of Complementary and Alternative Medicine in the context of cancer; prevalence, reasons for use, disclosure, information received, risks and benefits reported by people with cancer in Norway
por: Kristoffersen, Agnete E., et al.
Publicado: (2022) -
Conventional health care service utilization among cancer survivors that visit traditional and complementary providers in the Tromsø study: a cross-sectional study
por: Nakandi, Kiwumulo, et al.
Publicado: (2022) -
Clinical associations for traditional and complementary medicine use among norwegian cancer survivors in the seventh survey of the Tromsø study: a cross-sectional study
por: Nakandi, Kiwumulo, et al.
Publicado: (2023) -
Adherence to lifestyle recommendations among Norwegian cancer survivors and the impact of traditional and complementary medicine use: the Tromsø Study 2015–2016
por: Nakandi, Kiwumulo, et al.
Publicado: (2023) -
Prevalence, and health- and sociodemographic associations for visits to traditional and complementary medical providers in the seventh survey of the Tromsø study
por: Kristoffersen, Agnete E., et al.
Publicado: (2019)